PDE9 Inhibition Activates PPARa to Stimulate Mitochondrial Fat Metabolism and Reduce Cardiometabolic Syndrome
Mishra, S.; Hahn, V.; Sadagopan, N.; Dunkerly-Eyring, B.; Rodriguez, S.; Sarver, D. C.; Ceddia, R. P.; Murphy, S.; Knutsdottir, H.; Jani, V.; Ashok, D.; Oeing, C. U.; O'Rourke, B.; Sharma, K.; Gangoiti, J.; Sears, D. D.; Wong, G. W.; Collins, S.; Kass, D. A.
Show abstract
Central obesity with cardiometabolic syndrome (CMS) is a major global contributor to human disease, and effective therapies are needed. Here, we show inhibiting cyclic-GMP selective phosphodiesterase-9A (PDE9-I) suppresses established diet-induced obesity and CMS in ovariectomized female and male mice. PDE9-I reduces abdominal, hepatic, and myocardial fat accumulation, stimulates mitochondrial activity in brown and white fat, and improves CMS, without altering activity or food intake. PDE9 localizes to mitochondria, and its inhibition stimulates lipolysis and mitochondrial respiration coupled to PPAR-dependent gene regulation. PPAR upregulation is required for PDE9-I metabolic efficacy and is absent in non-ovariectomized females that also display no metabolic benefits from PDE9-I. The latter is compatible with estrogen receptor- altering PPAR chromatin binding identified by ChIPSeq. In humans with heart failure and preserved ejection fraction, myocardial expression of PPARA and its regulated genes is reduced versus control. These findings support testing PDE9-I to treat obesity/CMS in men and postmenopausal women. SummaryOral inhibition of phosphodiesterase type 9 stimulates mitochondrial fat metabolism and lipolysis, reducing central obesity without changing appetite
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Hepatic Mitochondrial Remodeling is Mechanistically Linked to Insulin Resistance in Nonalcoholic Fatty Liver Disease 95%
- Feeding desensitizes A1 adenosine receptors in adipose through FOXO1-mediated transcriptional regulation 95%
- Adipocyte-specific ablation of the Ca2+ pump SERCA2 impairs whole-body metabolic function and reveals the diverse metabolic flexibility of white and brown adipose tissue. 94%
Similar papers in this journal
Similar papers in this journal
- Long-term ketogenic diet causes hyperlipidemia, liver dysfunction, and glucose intolerance from impaired insulin trafficking and secretion in mice 94%
- PPP1R3B is a metabolic switch that shifts hepatic energy storage from lipid to glycogen 93%
- Transcriptional regulation of adipocyte lipolysis by IRF2BP2 93%
Similar papers in this journal
- Liver-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice 95%
- The human glucocorticoid receptor variant rs6190 promotes blood cholesterol and atherosclerosis 95%
- Phosphorylation of CRYAB Induces a Condensatopathy to Worsen Post-Myocardial Infarction Left Ventricular Remodeling. 93%
Similar papers in this journal
- Thrombospondin-1 promotes fibro-adipogenic stromal expansion and contractile dysfunction of the diaphragm in obesity 94%
- Perilipin2 down-regulation in beta cells impairs insulin secretion under nutritional stress and damages mitochondria 94%
- Beta-cell mass expansion during puberty involves serotonin signaling and determines glucose homeostasis in adulthood 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.